Loading...

Acrivon Therapeutics, Inc. Common Stock

ACRV•NASDAQ
Healthcare
Biotechnology
$1.89
$-0.08(-4.06%)
U.S. Market opens in 5h 39m

Acrivon Therapeutics, Inc. Common Stock (ACRV) Stock Overview

Explore Acrivon Therapeutics, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap59.6M
P/E Ratio-0.93
EPS (TTM)$-2.02
ROE-0.57%
Fundamental Analysis

AI Price Forecasts

1 Month$-1.23
3 Months$0.00
1 Year Target$0.00

ACRV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Acrivon Therapeutics, Inc. Common Stock (ACRV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.12, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.93 and a market capitalization of 59.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.06%
5-Day Change
11.18%
1-Month Change
18.13%
3-Month Change
-7.80%
6-Month Change
-5.50%
Year-to-Date (YTD) Change
-21.58%
1-Year Change
-5.50%
3-Year Change
-84.41%
5-Year Change
-88.64%
All-Time (Max) Change
-88.64%

Contact Information

https://www.acrivon.com
617-207-8979
480 Arsenal Way, Watertown, MA, 02472

Company Facts

75 Employees
IPO DateNov 15, 2022
CountryUS
Actively Trading

Frequently Asked Questions